Simvastatin Suppresses Apoptosis in Vulnerable Atherosclerotic Plaques Through Regulating the Expression of P(53), Bcl-2 and Bcl-Xl
Shu Wang
DOI: https://doi.org/10.1007/s10557-011-6347-z
2011-01-01
Cardiovascular Drugs and Therapy
Abstract:Simvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, has antioxidant and anti-inflammatory properties that are independent of lipid-lowering abilities. This experiment was carried out to explore the effects of simvastatin on apoptosis in vulnerable atherosclerotic plaques of apoE-deficient mice.
What problem does this paper attempt to address?